VENUS CONCEPT INC (VERO) Stock Price, Quote, News and Overview
NASDAQ:VERO - Nasdaq - US92332W2044 - Common Stock - Currency: USD
VERO Quote, Performance and Key Statistics
VENUS CONCEPT INC
NASDAQ:VERO (1/30/2025, 8:00:01 PM)
After market: 0.34 -0.01 (-3.44%)0.3521
-0.01 (-1.84%)
The current stock price of VERO is 0.3521 USD. In the past month the price decreased by -2.19%. In the past year, price decreased by -71.83%.
VERO Latest News, Press Releases and Analysis
Top movers in Monday's after hours session
Monday's after hours session: top gainers and losers
Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results
TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...
Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India
Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets...
Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024
TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...
VERO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.58 | 223.42B | ||
| ISRG | INTUITIVE SURGICAL INC | 79.15 | 206.65B | ||
| BSX | BOSTON SCIENTIFIC CORP | 43.66 | 151.86B | ||
| SYK | STRYKER CORP | 32.03 | 148.84B | ||
| MDT | MEDTRONIC PLC | 17.52 | 117.96B | ||
| BDX | BECTON DICKINSON AND CO | 18.88 | 72.06B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.42 | 43.19B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 21.22 | 40.91B | ||
| RMD | RESMED INC | 31.08 | 37.82B | ||
| IDXX | IDEXX LABORATORIES INC | 38.72 | 34.72B | ||
| DXCM | DEXCOM INC | 51.54 | 34.22B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.93 | 26.36B |
Related stock screener links
About VERO
Company Profile
Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 304 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and 10 direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Company Info
VENUS CONCEPT INC
235 Yorkland Blvd Suite 900
TORONTO ONTARIO M2J 4Y8 CA
CEO: Domenic Serafino
Employees: 304
Company Website: https://www.venusconcept.com/en-uk/
Investor Relations: http://www.ir.venusconcept.com
Phone: 18778488430
VERO FAQ
What is the stock price of VERO?
The current stock price of VERO is 0.3521 USD.
What is the symbol for VENUS CONCEPT INC stock?
The exchange symbol of VENUS CONCEPT INC is VERO and it is listed on the Nasdaq exchange.
On which exchange is VERO stock listed?
VERO stock is listed on the Nasdaq exchange.
Is VERO a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for VERO, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of VERO.
Does VERO stock pay dividends?
VERO does not pay a dividend.
What is the Price/Earnings (PE) ratio of VERO?
VERO does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.02).
What is the Short Interest ratio of VERO stock?
The outstanding short interest for VERO is 0.83% of its float.
VERO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to VERO. When comparing the yearly performance of all stocks, VERO is a bad performer in the overall market: 94.89% of all stocks are doing better.
VERO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VERO. VERO has a bad profitability rating. Also its financial health evaluation is rather negative.
VERO Financial Highlights
Over the last trailing twelve months VERO reported a non-GAAP Earnings per Share(EPS) of -8.02. The EPS decreased by -15.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.38% | ||
| ROE | -496.11% | ||
| Debt/Equity | 3.4 |
VERO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to VERO. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -1.6% and a revenue growth -17.86% for VERO